Jamin D. Steffen
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Physiology top 5%
Papers in
-
- DNA Repair Mechanisms 6
- Cell death mechanisms and regulation 2
- CRISPR and Genetic Engineering 2
- Oncology 8
- PARP inhibition in cancer therapy 8
- Co-authors
- John M. Pascal (7 shared papers)Marie-France Langelier (4 shared papers)Michael McCauley (3 shared papers)Ben E. Black (2 shared papers)Jonathan R. Brody (2 shared papers)Amanda A. Riccio (2 shared papers)Roger S. Armen (1 shared paper)Jamie E. DeNizio (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Cancer Research (1 paper)Molecular Cell (1 paper)Journal of Clinical Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Jamin D. Steffen
14 papers receiving 992 citations
Peers
Comparison fields: 5 of 74
- Oncology 741
- Physiology 54
- Molecular Biology 608
- Toxicology 28
- Immunology 160
Countries citing papers authored by Jamin D. Steffen
This map shows the geographic impact of Jamin D. Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamin D. Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamin D. Steffen more than expected).
Fields of papers citing papers by Jamin D. Steffen
This network shows the impact of papers produced by Jamin D. Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamin D. Steffen. The network helps show where Jamin D. Steffen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jamin D. Steffen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 283 | |
| 2 | 2020 | 241 | |
| 3 | 2013 | 128 | |
| 4 | 2007 | 59 | |
| 5 | 2013 | 52 | |
| 6 | 2014 | 49 | |
| 7 | 2017 | 48 | |
| 8 | 2016 | 39 | |
| 9 | 2017 | 33 | |
| 10 | 2011 | 33 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 11 | |
| 13 | 2021 | 7 | |
| 14 | Diagnosis and treatment of breast cancer | 2003 | 3 |
| 15 | 2004 | 1 | |
| 16 | Studies on the Nijmegen breakage syndrome offer an insight into the mechanisms of tumour development resulting from defects of DNA double-strand break repair | 2000 | 0 |
About Jamin D. Steffen
Jamin D. Steffen is a scholar working on Molecular Biology, Oncology, Immunology, Electrical and Electronic Engineering and Pathology and Forensic Medicine, having authored 16 papers that have together received 1000 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (6 papers), Toxin Mechanisms and Immunotoxins (4 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers), Cell death mechanisms and regulation (2 papers), Genetic factors in colorectal cancer (2 papers), CRISPR and Genetic Engineering (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (741 citations), Physiology (54 citations), Molecular Biology (608 citations), Toxicology (28 citations) and Immunology (160 citations). Jamin D. Steffen has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include John M. Pascal, Marie-France Langelier, Michael McCauley, Ben E. Black, Jonathan R. Brody, Amanda A. Riccio, Roger S. Armen, Jamie E. DeNizio, Jennine M. Dawicki-McKenna and Connie D. Cao. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Molecular Cell, Journal of Clinical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.